Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Recro Pharma Inc (NASDAQ:REPH)

7.68
Delayed Data
As of 3:59pm ET
 -0.08 / -1.03%
Today’s Change
5.59
Today|||52-Week Range
17.25
-14.67%
Year-to-Date
No recent news for Recro Pharma Inc.

Today’s Trading

Previous close7.76
Today’s open7.80
Day’s range7.63 - 7.80
Volume8,951
Average volume (3 months)18,334
Market cap$73.5M
Dividend yield--
Data as of 3:59pm ET, 07/26/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-1,721.43%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio256.0
Price/Sales1.52
Price/Book1.77

Competitors

 Today’s
change
Today’s
% change
CERUCerulean Pharma Inc-0.02-0.73%
NVLSNivalis Therapeutics...-0.07-1.52%
MBRXMoleculin Biotech In...+0.15+2.21%
SBPHSpring Bank Pharmace...-0.47-5.22%
Data as of 3:59pm ET, 07/26/2016

Financials

Next reporting dateAugust 9, 2016
EPS forecast (this quarter)-$0.78
Annual revenue (last year)$52.0M
Annual profit (last year)$3.0M
Net profit margin5.84%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Gerri Henwood
Chief Financial Officer
Michael Celano
Corporate headquarters
Malvern, Pennsylvania

Forecasts

Partner Offers

Search for Jobs